Slingshot members are tracking this event:
AbbVie's (ABBV) Investigational HCV Regimen Receives U.S. FDA Breakthrough Therapy Designation
Slingshot Insights Explained
Sep 30, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Hcv Regimen, Breakthrough Therapy Designation